275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
Corporate VP, Alberto Grignolo
We are proud to provide the highest quality in trial design and conduct (according to customer feedback). We aim for meaningful clinical benefits, with the patient as our guide, yet mindful that time to market is of the essence,. We build efficiency and precision into our trial design. A team of dedicated integrated solution strategists and feasibility leaders, supported by Parexel’s peerless regulatory and market access experts, cover every stage of drug development.
From highly prevalent to ultra rare diseases, we are prepared to operate the full spectrum of study size from mega-trials for highly prevalent diseases to trials with few patientes for a rare condition. Whether a study needs to recruit 16,000 patientes for a Cardiovascular Outcome Trial or a study needs only 150 patients in an ultrarare respiratory condision, we manage them all with equal importance. We have a pulse on the latest trends and technologies to help scale a trial towards success (i.e. platform trials, adaptive designs, use of synthetic/external control arm, convergence of Real-World Studies and Interventional Design, etc.)
A strong emphasis on preventative health, especially for women and those living with diabetes
Deep partnerships with patient and caregiver advocacy groups to inform our research.
Broad expertise in patient recruitment, including access to pediatrics.
A bird’s-eye view of trends in the various specialty areas, as well as developments in treating rare diseases, including gene therapy.
Extensive experience in biotech, including in Asia and studies involving novel drugs, biologics and biosimilars.
Vast expertise in innovative trial design and digital medicine, including virtual, decentralized, and adaptive trials; precision and translational medicine; and sensor solutions.
Transparent communications throughout the drug development process, clearly articulating issues that arise such as side effects or potential obstacles to regulatory approval.
A commitment to building collaborative, trusting relationships with our clients.
Parexel has far-reaching experience in clinical trials across the entire spectrum of drugs and medical devices, including heart failure, ...
Parexel has far-reaching experience in clinical trials across the entire spectrum of drugs and medical devices, including heart failure, hypertension, pulmonary hypertension, atherosclerosis and myocardial infarction, atrial fibrillation, and thrombosis, to name a few. Our board-certified cardiologists, top-notch biostatisticians, and regulatory, product development and market access specialists are always ready to engage in study design optimization and strategy development.
From the millions affected by asthma and COPD to the hundreds affected by rare diseases, bringing innovation or more ...
From the millions affected by asthma and COPD to the hundreds affected by rare diseases, bringing innovation or more affordable treatments to patients is our passion. Parexel has conducted studies in asthma and COPD involving many thousands of patients and more than 3,000 sites globally, including one of the largest observational asthma trials ever conducted. Likewise, our expertise spans studies in Interstitial Lung Disease, Cystic Fibrosis, Chronic Cough, and Orphan Diseases. Through partnerships with the leading pharma companies and biotech innovators, we collaborate with the full ecosystem of respiratory disease research. As a single point of contact, we integrate meaningful data to assess treatment efficacy in an interventional trial and relevant insights in the real world of respiratory disease.
Our projects cover the spectrum from small studies of rare metabolic diseases to Type 2 diabetes “mega-trials” ...
Our projects cover the spectrum from small studies of rare metabolic diseases to Type 2 diabetes “mega-trials” enrolling thousands. Parexel fulfills the unique needs of each study with strong site networks and recruitment solutions, including both adult and pediatric studies. Sensor solutions for diabetes studies are another area of exceptional expertise, including 21 CFR part 11–compliant continuous glucose monitoring. Our team includes board-certified adult and pediatric endocrinologists, certified clinical densitometrists, glucose-clamp expertise, and the top-quality regulatory, market access and biostatistics experts you expect with Parexel.
Parexel played a significant role in development of all three women’s health products approved by the ...
Parexel played a significant role in development of all three women’s health products approved by the FDA in 2020 (non-hormonal on-demand contraceptive, hormonal contraceptive, and management of heavy menstrual bleeding due to uterine fibroids). Our expertise spans the woman’s lifetime, encompassing preadolescent care, menstrual and pelvic health, fertility management, pregnancy, menopausal care, and mental health.
As we enter a new era with breakthroughs for chronic kidney and urinary system diseases, Parexel is helping sponsors ...
As we enter a new era with breakthroughs for chronic kidney and urinary system diseases, Parexel is helping sponsors overcome obstacles in this area – for example, patient recruitment and payer engagement. Parexel strengths are demonstrated with delivery on major studies in this area, including Diabetic and Polycystic Kidney Diseases, urinary incontinence, overactive bladder, and Benign Prostatic Hyperplasia.
We are always available for a conversation.
